Skip to content

Evaluation of the Prevalence of Anti-infective Drug Compliance in Pediatric Patients Hospitalized at Nimes University Hospital After Return Home

Evaluation of the Prevalence of Anti-infective Drug Compliance in Pediatric Patients Hospitalized at Nimes University Hospital After Return Home

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04009785
Acronym
PEDIAOBST
Enrollment
75
Registered
2019-07-05
Start date
2018-03-06
Completion date
2018-05-04
Last updated
2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anti Infective, Pediatric Population

Brief summary

Nowadays, resistance to anti-infectives has become a global public health problem and its increased prevalence threatens human health. To date, few studies have focused on drug compliance in the paediatric population and it varies according to the pathology This drug adherence in the paediatric population is directly linked to outpatient care by the parents or the child's immediate family. In addition, there are no studies on adherence to antibiotics prescribed at the end of hospitalization in the paediatric population. In this context, it seems urgent to seek an intervention capable of leading to responsible and appropriate use of antibiotics in order to improve efficiency in the drug management of acute paediatric infections. This pilot study would characterize pediatric patients and determine the compliance rate in this population.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* The patient is under 16 years of age (\< 16 years of age). * The patient is admitted to a full hospitalization in one of the 2 paediatric units of the University Hospital of Nîmes. * The patient is discharged with a prescription for anti-infectives to be taken at home, for a maximum of 30 days. * The patient and the holder of parental authority are available for a follow-up of 1 month after discharge from hospital.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Rate of patients observing anti-infectives2018

Secondary

MeasureTime frame
Rehospitalization rates / emergency visits related to worsening infection2018

Other

MeasureTime frame
Rate of observing patients who have recovered their anti-infective treatment2018
Rate of observing patients who have taken anti-infective treatment as prescribed2018
Sociodemographic and clinical characteristics2018
Overall success rate in the quiz on understanding anti-infectives2018

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026